Desoxo-palbociclib is a derivative compound of Palbociclib. Palbociclib is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
Shipping Condition
Ambient
Inventory Status
Under Development
Quantity
Additonal Comment
Add to Cart
Bulk Enquiry
Chemical Name: Desoxo-palbociclib
Synonym: Palbociclib Impurity-2; Palbociclib Impurity D